Literature DB >> 26695351

Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation.

Alex Cordero1, Pasquale Pellegrini1, Adrián Sanz-Moreno1, Eva M Trinidad1, Jordi Serra-Musach2, Chetan Deshpande3, William C Dougall4, Miguel Angel Pujana2, Eva González-Suárez1.   

Abstract

Prolactin and progesterone both orchestrate the proliferation and differentiation of the mammary gland during gestation. Differentiation of milk secreting alveoli depends on the presence of prolactin receptor, the downstream Jak2-Stat5 pathway and the transcription factor Elf5. A strict regulation of Rank signaling is essential for the differentiation of the mammary gland and in particular for alveolar commitment. Impaired alveologenesis and lactation failure are observed in both, knockout and Rank overexpressing mice; however, the underlying molecular mechanism responsible for these phenotypes remains largely unknown. Using genome-wide expression analyses and functional studies, we show here that Rankl (RL) exposure leads to impaired secretory differentiation of alveolar cells not only in MMTV-RANK but also in wild-type (WT) mammary acini. Conversely, pharmacological blockage of Rank signaling at midgestation in WT mice leads to precocious and exacerbated lactogenesis. Mechanistically, RL negatively regulates Stat5 phosphorylation and Elf5 expression at the onset of lactogenesis. Continuous RL exposure leads to the expansion of basal and bipotent cells in WT and MMTV-RANK acini. Overall, we demonstrate that enhanced Rank signaling impairs secretory differentiation during pregnancy by inhibition of the prolactin/p-Stat5 pathway.
© 2015 AlphaMed Press.

Entities:  

Keywords:  Mammary alveoli; Progesterone; Prolactin; Rank; Rankl; p-Stat5

Mesh:

Substances:

Year:  2016        PMID: 26695351     DOI: 10.1002/stem.2271

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  13 in total

1.  Attenuation of Mammary Gland Dysplasia and Feeding Difficulties in Tabby Mice by Fetal Therapy.

Authors:  Mandy Wahlbuhl; Sonia Schuepbach-Mallepell; Christine Kowalczyk-Quintas; Angela Dick; Fabian B Fahlbusch; Pascal Schneider; Holm Schneider
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-06-01       Impact factor: 2.673

Review 2.  Progesterone and Breast Cancer.

Authors:  Britton Trabert; Mark E Sherman; Nagarajan Kannan; Frank Z Stanczyk
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

3.  A human breast atlas integrating single-cell proteomics and transcriptomics.

Authors:  G Kenneth Gray; Carman Man-Chung Li; Jennifer M Rosenbluth; Laura M Selfors; Nomeda Girnius; Jia-Ren Lin; Ron C J Schackmann; Walter L Goh; Kaitlin Moore; Hana K Shapiro; Shaolin Mei; Kurt D'Andrea; Katherine L Nathanson; Peter K Sorger; Sandro Santagata; Aviv Regev; Judy E Garber; Deborah A Dillon; Joan S Brugge
Journal:  Dev Cell       Date:  2022-05-25       Impact factor: 13.417

4.  Hormone and receptor activator of NF-κB (RANK) pathway gene expression in plasma and mammographic breast density in postmenopausal women.

Authors:  Rachel Mintz; Mei Wang; Shuai Xu; Graham A Colditz; Chris Markovic; Adetunji T Toriola
Journal:  Breast Cancer Res       Date:  2022-04-14       Impact factor: 6.466

Review 5.  What Is Breast in the Bone?

Authors:  Carrie S Shemanko; Yingying Cong; Amanda Forsyth
Journal:  Int J Mol Sci       Date:  2016-10-22       Impact factor: 5.923

6.  RANKL/RANK control Brca1 mutation- .

Authors:  Verena Sigl; Kwadwo Owusu-Boaitey; Purna A Joshi; Anoop Kavirayani; Gerald Wirnsberger; Maria Novatchkova; Ivona Kozieradzki; Daniel Schramek; Nnamdi Edokobi; Jerome Hersl; Aishia Sampson; Ashley Odai-Afotey; Conxi Lazaro; Eva Gonzalez-Suarez; Miguel A Pujana; For Cimba; Holger Heyn; Enrique Vidal; Jennifer Cruickshank; Hal Berman; Renu Sarao; Melita Ticevic; Iris Uribesalgo; Luigi Tortola; Shuan Rao; Yen Tan; Georg Pfeiler; Eva Yhp Lee; Zsuzsanna Bago-Horvath; Lukas Kenner; Helmuth Popper; Christian Singer; Rama Khokha; Laundette P Jones; Josef M Penninger
Journal:  Cell Res       Date:  2016-05-31       Impact factor: 25.617

7.  BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells.

Authors:  Elisabet Cuyàs; Bruna Corominas-Faja; María Muñoz-San Martín; Begoña Martin-Castillo; Ruth Lupu; Joan Brunet; Joaquim Bosch-Barrera; Javier A Menendez
Journal:  Oncotarget       Date:  2017-05-23

8.  Characterization of Gene Expression Signatures for the Identification of Cellular Heterogeneity in the Developing Mammary Gland.

Authors:  Samantha Henry; Marygrace C Trousdell; Samantha L Cyrill; Yixin Zhao; Mary J Feigman; Julia M Bouhuis; Dominik A Aylard; Adam Siepel; Camila O Dos Santos
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-05-14       Impact factor: 2.673

Review 9.  The molecular basis of mammary gland development and epithelial differentiation.

Authors:  Priscila Ferreira Slepicka; Amritha Varshini Hanasoge Somasundara; Camila O Dos Santos
Journal:  Semin Cell Dev Biol       Date:  2020-10-17       Impact factor: 7.499

10.  Luminal STAT5 mediates H2AX promoter activity in distinct population of basal mammary epithelial cells.

Authors:  Moshe Reichenstein; Gat Rauner; Shenhav Kfir; Tatiana Kisliouk; Itamar Barash
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.